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background: Hypothyroidism can cause reduced cardiac contractility and deterioration of heart failure (HF), whereas the decrease in thyroid 
hormone levels during severe illness could be protective against excessive tissue catabolism. Although the prognostic impact of subclinical 
hypothyroidism (SCH) in the chronic phase of HF has been reported, its impact in the acute decompensated phase has not been investigated.
Methods: We examined consecutive 192 patients with acute decompensated HF (ADHF) who received thyroid function tests at admission (age 
67±14 years, 110 male). We compared the following 2 groups determined by thyroid-stimulation hormone (TSH) level: euthyroidism (n=127) defined 
as TSH of 0.45 to 4.49 mIU/L and SCH (n=46) as TSH of 4.5 to 19.9 mIU/L with normal free thyroxine level.
results: Although age, sex, etiology of HF, left ventricular ejection fraction (LVEF) and B-type natriuretic peptide (BNP) level were comparable 
between the 2 groups, SCH patients had lower estimated glomerular filtration rate (eGFR) than euthyroidism patients (67±33 vs. 81±35 ml/
min/1.73m2, p=0.018) and a higher prevalence of adverse cardiac events (Figure). Cox proportional hazards model analysis revealed that SCH 
was an independent predictor of adverse cardiac events (HR 2.55, 95% CI 1.50-4.33, p < 0.001) among variables including age, sex, LVEF, BNP and 
eGFR.
conclusions: SCH in ADHF patients is an independent predictor of adverse cardiac events. 
